glp 1 receptor agonist contraindications Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs Glp 1 Contraindications

& Szegedy, C

Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: A systematic review and development of recommendations to reduce inappropriate prescribing

2123 The Effect of GLP-1RAs on Systemic Inflammation The ability of GLP-1RAs to reduce systemic inflammation (with decreases in hs-C-reactive protein, TNF-, interleukin-6 and interleukin IL-1) has been demonstrated in animal studies, studies on isolated human tissues and RCTs

Statements Author contributions DM: Screening and selection of studies, extraction of study data, contact with Lareb and the TIS of Switzerland, main author of the manuscript

These findings underscore GLP-1 as a pivotal molecular link bridging metabolic and immune pathways (Lincoff et al., 2023)

References 1 CuadrosDFLiJMusukaGAwadSF